7th national meeting on interventional...

CROINTERVENT2016www.crointervent2016.org

7th National Meeting onInterventional

Cardiologywith International Participation

10-12 March, 2016, Zagreb, Hotel The Westin, Croatia

Working Group for Interventional Cardiology of the Croatian Cardiac Society

Završni program / Final Programme

3

POZDRAVNI GOVOR / WELCOME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 04

ORGANIZACIJSKI ODBOR / ORGANIZING COMMITTEE . . . . . . . . . . . . . . . . . . . . . 06

SPONZORI / SPONSORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 09

ZNANSTVENI PROGRAM / SCIENTIFIC PROGRAMME . . . . . . . . . . . . . . . . . . . . . . . . 10

ZNANSTVENI PROGRAM / SCIENTIFIC PROGRAMME . . . . . . . . . . . . . . . . . . . . . . . . 18VI. sastanak intervencijskih kardioloških medicinskih sestara i tehničara / Meeting of Interventional Cardiology Nurses and Technicians

OPĆE INFORMACIJE / GENERAL INFORMATION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20

ZAGREB / ZAGREB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24

BILJEŠKE / NOTES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27

www.crointervent2016.org

SADRŽAJ / CONTENT

4 www.crointervent2016.org

Poštovane kolegice i kolege,

Radna skupina za invazivnu i intervencijsku kardiologiju Hrvatskoga kardiološkog društva

organizira 7. nacionalni kongres intervencijske kardiologije s međunarodnim sudjelovanjem

- CROINTERVENT 2016. koji će se održati od 10.-12. ožujka, 2016. godine u Zagrebu. Isto-

vremeno će se održati i 6. sastanak Radne skupine za invazivnu i intervencijsku kardiologiju

Hrvatske udruge kardioloških medicinskih sestara. CROINTERVENT 2016. namijenjen je ne

samo kardiolozima i specijalizantima kardiologije, nego i liječnicima drugih specijalnosti te

osobama koje su profesionalno vezane uz ovaj dinamičan i propulzivan segment moderne

medicine. Cilj kongresa je, osim prikaza moderne kliničke prakse u intervencijskoj kardiologiji,

raspraviti nedoumice i probleme koje susrećemo u svom radu, a oko kojih još ne postoji

suglasje. U programu kongresa bit će zastupljena pozvana predavanja, oralne i moderirane

poster prezentacije, panel diskusije i satelitski simpoziji. Kao i do sada, značajan dio kongresa

posvetit ćemo praktičnim aspektima intervencijske kardiologije, kako putem direktnih pri-

jenosa zahvata uz interakciju s operaterima, tako i prikazivanjem već učinjenih intervencija

s analizom i komentarima. Srdačno Vas pozivam da svojim prisustvom i aktivnim sudjelova-

njem doprinesete uspjehu našeg nacionalnog kongresa.

Za organizacijski odbor:

Doc. dr. sc. Eduard Margetić

Predsjednik Radne skupine

za invazivnu i intervencijsku kardiologiju

Hrvatskoga kardiološkog društva

DOBRODOŠLI / WELCOME

5www.crointervent2016.org

Dear Colleagues,

The working group for Invasive and Interventional Cardiology of the Croatian Cardiac Soci-

ety is organizing the 7th National Congress of interventional cardiology with international

participation - CROINTERVENT 2016, which will be held from 10.-12. March 2016 in Zagreb.

At the same time the 6th Meeting of the Working Group for Invasive and Interventional Car-

diology of the Croatian Cardiac Nurses will be held. CROINTERVENT 2016 is designed not

only for cardiologists and cardiology fellows, but also for doctors of other specialties and

people who are professionally associated with this dynamic and propulsive segment of mod-

ern medicine. The aim of the Congress is, besides the display of modern clinical practice in

interventional cardiology, to discuss concerns and problems that we encounter in our daily

practice, especially ones still without consensus among the interventional cardiologists. The

congress program will consist of invited lectures, oral and moderated poster presentations,

panel discussions and satellite symposia. As before, a significant part of the congress will be

given to the practical aspects of interventional cardiology, both through transmitted “live

cases” and presentation of already performed interventions with analysis and comments. I

cordially invite you to attend CROINTERVENT 2016 and contribute to the success of our Na-

tional Congress.

Za organizacijski odbor:

Assoc. Prof. Eduard Margetić, M.D., Ph.D.

President Working Group for Invasive

and Interventional Cardiology

Croatian Cardiac Society


ORGANIZACIJSKI ODBOR / ORGANIZING COMMITTEE

Organizator / Organizer

▪ Radna skupina za invazivnu i intervencijsku kardiologiju Hrvatskoga kardiološkog društva

▪ Working Group for Interventional Cardiology of the Croatian Cardiac Society

Predsjednik kongresa / Meeting President

Eduard Margetić

▪ Radna skupina za intervencijsku kardiologiju Hrvatske udruge kardioloških medicinskih sestara

▪ Working Group for Interventional Cardiology of the Croatian Association of Cardiology Nurses

Predsjednici sastanka / Meeting President

Ivica Benko

Marija Matoš

Organizacijski odbor / Organizing Committee

Z. Babić, Zagreb

Ž. Baričević, Zagreb

J. Bulum, Zagreb

E. Galić, Zagreb

L. Giunio, Split

D. Kozmar, Zagreb

T. Krčmar, Zagreb

Pozvani predavači / International Faculty

K. Bonaventura (D) / M. Bunc (SLO) / S. Colangelo (I) / M. Čerček (SLO) / A. Halkin (IL) /

A. Lazarević (RS) / M. Nedeljković (SRB) / R. Petraco (UK) / S. Stojković (SRB) / G. Tarantini (I) /

I. Terzić (BIH) / M. Vidovich (USA)

Z. Makarović, Osijek

K. Marić Bešić, Zagreb

D. Miličić, Zagreb

Z. Miovski, Zagreb

H. Pintarić, Zagreb

Đ. Prvulović, Sl. Brod

B. Skorić, Zagreb

R. Steiner, Osijek

M. Strozzi, Zagreb

J. Šikić, Zagreb

K. Štambuk, Krapinske Toplice

V.Tomulić, Rijeka

I. Vuković, Split

D. Zekanović, Zadar

J. Daskijević, Zagreb

I. Ferjančić, Zadar

A. Ljubas, Zagreb

R.Pervan, Krapinske Toplice

Comfort. Protection. FlexibilityThe Zero-Gravity suspended radiation protection system is designed to increase the level of radiation protection and at the same time eliminate the weight burden for the operator.

ComfortZero-Gravity allows freedom of movement during procedures and relieves orthopedic strain.

ProtectionZero-Gravity far surpasses the partial radiation protection of conventional aprons.

FlexibilityZero-Gravity can be adapted to a broad range of procedures and room confi gurations.

Zero-GravityTM

Safety and Comfort in Radiation Protection

Comfort. Protection. FlexibilityThe Zero-Gravity suspended radiation protection system is designed to increase the level of radiation protection and at the same time eliminate the weight burden for the operator.

ComfortZero-Gravity allows freedom of movement during procedures and relieves orthopedic strain.

ProtectionZero-Gravity far surpasses the partial radiation protection of conventional aprons.

FlexibilityZero-Gravity can be adapted to a broad range of procedures and room confi gurations.

Zero-GravityTM

Safety and Comfort in Radiation Protection


SPONZORI / SPONSORS

Abbott Laboratories d.o.o.

Boehringer Ingelheim d.o.o.

Kefo d.o.o.

Merck Sharp & Dohme

Shimadzu d.o.o. Sonimed d.o.o.

Bayer d.o.o.

Pliva Hrvatska d.o.o. Siemens d.o.o.

Bormiamed d.o.o.

Krka Farma d.o.o.

Novartis Hrvatska d.o.o.

B. Braun Adria d.o.o.

Boston Scientific

Medical Intertrade d.o.o.

Sanyko d.o.o.

Biotronik d.o.o.

AstraZeneca d.o.o.

GE Healtcare d.o.o.

Medicom

Servier Pharma d.o.o.

Zlatni sponzor

Srebrni sponzori

Brončani sponzori

Ostali sponzori

Mark Medical d.o.o. Medtronic Adriatic d.o.o. Pfizer Croatia d.o.o.


ZNANSTVENI PROGRAM / SCIENTIFIC PROGRAMME

Thursday, 10.3.2016.

18:00 - 18:30 Opening ceremony

18:30 - 19:00 Concert - Lege Artis Student Choir School of Medicine, University of Zagreb

19:00 - 19:20 Award for Lifetime Achievement in Interventional Cardiology

19:20 - 19:50 Opening Lecture: Public Reporting of Cardiology Outcomes - M. Vidovich

20:00 - 22:00 Welcome reception

Friday 11.3.2016.

Imaging TechniquesChairman: M. Čerček, M. Jukić, M. Vidovich

08:15 - 08:30M. Jukić, L. Pavić, P. Medaković, D. Lovrić, I. Bitunjac

ZagrebThe role of coronary CT angiography in the field of interventional cardiology

08:30 - 08:45K. Gabaldo, Đ. Prvulović, B. Vujeva, I. Hadžibegović, O. Čančarević

S. BrodClear stent imaging for guiding the complex coronary interventions

08:45 - 09:05 M. Čerček LjubljanaIVUS use in everyday practice - experience from Ljubljana

09:05 - 09:25 M. Vidovich Chicago Optical Coherence Tomography

Complex Lesions 1.Chairman: E. Galić, B. Skorić, M. Strozzi

09:25 - 09:40 B. Skorić ZagrebRotational atherectomy in complex calcified coronary lesions

09:40 - 09:55 M. Strozzi ZagrebRecent recommendation for bifurcation PCI and our Immediate and long-term results in this patient group

09:55 - 10:10 M. Sičaja, B. Starčević ZagrebDrug eluting balloon-side branch with/without cross-stenting technique - alternatives for conventional bifurcation stenting?

10:10 - 10:25 T. Letilović, D. Kozmar ZagrebUse of guide extension devices in Clinical Hospital Merkur? - initial experiences


LIVE CASE transmissionChairman: J. Bulum, M. Čerček, V. Tomulić

10:25 - 11:25Case 1. (E. Margetić, Z. Makarović)

Case 2. (K. Bonaventura, K. Marić Bešić)

11:25 - 11:40 Coffee Break

Complex Lesions 2.Chairman: J. Bulum, H. Stipić, S. Stojković

11:40 - 11:55 H. Stipić K. TopliceThe dysfunction of LIMA - opportunities and risks of secondary percutaneous revascularization

11:55 - 12:15 S. Stojković BelgradeContemporary indications for percutaneous revas-cularization of coronary chronic total occlusions

12:15 - 12:30 K. Štambuk K. ToplicePercutaneous coronary intervention in patients unsuitable for surgical revascularization

12:30 - 12:45K. Marić Bešić, Z.Miovski, M.Strozzi

Zagreb Octogenarians in the cath lab

LIVE CASE transmissionChairman: K. Marić Bešić, H. Stipić, S. Stojković

12:45 - 13:45Case 3. (J. Šikić, T. Šipić) Case 4. (V. Tomulić, T. Krčmar, D. Zekanović)

13:45 - 14:30 Lunch Break

BVS / DEB / DES / BMS 1.Chairman: E. Margetić, R. Steiner, M. Sičaja

14:30 - 14:50 K. Bonaventura Potsdam Drug-coated balloons for de novo coronary lesions

14:50 - 15:10 G. Tarantini PaduaOptimal patient selection with Bioresorbable Vascular Scaffolds

15:10 - 15:30 S. Colangelo TurinClinical efficacy of the polymer-free Amphilimus Eluting DES in diabetic patients


Non Angiographic Methods in Evaluation of Coronary Flow Chairman: E. Margetić, R. Steiner, M. Sičaja

15:30 - 15:50 R. Petraco London Physiology, From Justification To Guidance

LIVE CASE transmissionChairman: E. Margetić, G. Tarantini, M. Vidovich

15:50 - 16:50Case 5. (J. Bulum, T. Letilović)

Case 6. (B. Skorić, K. Marić Bešić, E. Galić)

BVS / DEB / DES / BMS 2.Chairman: T. Krčmar, J. Šikić, D. Kozmar

16:50 - 17:05 J. Šikić ZagrebDES vs. BVS vs. DEB: advantages and problems of new technologies

17:05 - 17:20Đ. Prvulović, I. Hadžibegović, B.Vujeva, K.Gabaldo, O.Čančarević

Zagreb

Differences in serum concentration of vascular cell adhesion molecules (sVCAM-1) in patients treated with percutaneous balloon dilatation with stent implantation, and patients treated with paclitaxel-coated balloon

17:20 - 17:35T. Krčmar, H. Pintarić, N. Pavlović, Š. Manola, K. Štambuk, I. D. Gabrić, M. Vrsalović

ZagrebRare coronary artery reactions after DESimplantation


Structural Heart Disease InterventionsChairman: M. Bunc, A. Halkin, V. Tomulić

17:50 - 18:10 M. Nedeljković BelgradeInterventional treatment in atrial fibrillation - left atrial appendage occluders

18:10 - 18:30 A. Halkin Tel AvivLeft atrial appendage closure 2016: new data, evolving indications

18:30 - 18:45V. Tomulić, S.Brusich, T. Jakljević, K.Benko

RijekaLeft Atrial Appendage Occlusion - Starting a Program?

18:45 - 19:05 M. Bunc Ljubljana Transcuteneous valve replacement: up to date


19:05 - 19:20

J. Bulum, V. Tomulić, M. Strozzi, D. Gobić, I. Šafradin, I. Medved, J. Šeparovič-Hanževački, V. Ivančan, Z. Ostojić

ZagrebTranscatheter aortic valve implantation (TAVI) experience at UHC Zagreb and UHC Rijeka

19:20 - 19:35

R. Gabelica, M. Pavlek, Ž. Čolak, M. Mažar, G. Rajsman, S. Uzun, S. Konosić, D. Strapajević,V. Ivančan

ZagrebAnesthesia for interventional cardiology procedures

19:35 - 19:50I. Malčić, D. Šarić, H. Kniewald, D. Dilber, D. Bartoniček, D. Anić, V. Ivančan, D. Belina, A. Hodalin

ZagrebIntervention methods in pediatric cardiology in a 20 year period

19:50 - 20:05 M. Strozzi ZagrebPatients with adult congenital heart disease (ACHD), a new target for interventional cardiologist: what should we know?

Saturday 12.3.2016.

Emergencies in cath labChairman. L. Giunio, D. Gobić, Z. Makarović

08:15 - 08:30 E. Avdović, K. Uglešić, D. Gobić RijekaThrombectomy in High Risk Pulmonary Thromboembolism

08:30 - 08:45 L. Giunio SplitNews, controversy and our experience ininterventional treatment of massive and submassive pulmonary embolism

08:45 - 09:00B. Vujeva, Đ. Prvulović, K. Gabaldo, O. Čančarević, I. Hadžibegović

S. BrodThrombus aspiration in stemi before and after taste trial: experience from western Slavonia PPCI network

09:00 - 09:15 Š. Manola, V. Radeljić, N. Pavlović Zagreb Arrhythmias in acute coronary syndrome

09:15 - 09:30 Z. Makarović OsijekUse of intraaortic balloon pump in acute aoronary syndrome patients and cardiogenic shock in KBC Osijek, in period from 2014 to 2015.

9:30 - 9:45 D. Gobić RijekaExtracorporeal Membraneous Oxygenation in urgent and elective PCI


Anticoagulant and Antiplatelet Therapy in PCI Chairman: A. Lazarević, K. Štambuk

09:45 - 10:05 A. Lazarević B. Luka Clinical Trials of DAPT Duration after PCI

10:05 - 10:20 J. Samardžić Zagreb Clopidogrel resistance - an overview

10:20 - 10:35 E. Margetić ZagrebTriple therapy after PCI in patients with atrial fibrilation

10:35 - 10:50 K. Štambuk K. TopliceMore efficient and safer prevention of stroke in NVAF - Dual risk reduction

10:50 - 11:05 I. Šesto K. TopliceThe role of medical therapy in patients with advanced coronary artery disease


The third generation of antiplatelet therapy in acute coronary syndromeChairman: E. Margetić, Z. Babić

11:25 - 11:40 E. Margetić ZagrebThe importance of third generation antiplatelet drugs in acute coronary syndrome

11:40 - 11:55 V. Tomulić RijekaThe Regional Strategy in ACS Management - Organization, Results and Problems

11:55 - 12:10 K. Štambuk K. Toplice

Management of patients with acute myocardial infarction in Krapina-Zagorje County – focus on new strategies for administration of antiplatelet therapy (pilot project)

12:10 - 12:25M. Trbušić, Z. Babić, D. Balenović, A. Grman-Fanfani, I. Zadro, H. Pintarić

ZagrebHow to shorten the pain to balloon time in Croatian Primary Percutaneous Coronary Intervention

12:25 - 12:40I. Hadžibegović, Đ. Prvulović, K. Gabaldo, O. Čančarević, B. Vujeva

S. BrodAnticoagulation and antiaggregation pretreat-ment in NSTEMI

12:40 - 12:55 Z. Babić ZagrebThe third generation of antiplatelet therapy in acute myocardial infarction in Croatia - current status and future plans



Primary PCI network Chairman: Z. Babić, I. Terzić, D. Zekanović

13:30 - 13:45 M. Terzić TuzlaTreatment of patients with myocardial infarction in Bosnia and Herzegovina

13:45 - 13:55 Z. Babić ZagrebNews and future plans in Croatian primary PCI network

13:55 - 14:55Delegates from Croatian PCI network participating centers

Acute myocardial infarction treatment results of interventional centers in Croatia in 2014 and 2015

14:55-15:05 E. Galić, E. Margetić, Z. Babić ZagrebCurrent status of the Croatian national registry for invasive and interventional cardiology and acute coronary syndrome

15:05-15:10 Z. Babić, M. Pavlov Zagreb Conclusion


Case reportsChairman: Ž. Baričević, I. Hadžibegović, M. Trbušić

15:30 - 15:40 J. Bulum Zagreb From rotablation to bifurcation

15:40 - 15:50T. Krčmar, O. Vinter, N. Kos, H. Pintarić

Zagreb

A transradial percutaneous coronary interven-tion for complex lesions of the left main coronary artery and first obtuse marginal branch using a 7 French guiding catheter

15:50 - 16:00Ž. Baričević, K. Marić Bešić, M. Strozzi

ZagrebVariant angina in a patient with non-obstructive atherosclerotic coronary lesion and myocardial bridging- a puzzle not so easy to solve

16:00 - 16:10 G. Milašin K. ToplicePercutaneous closure of paraaortal "leak-a" and PCI of a vein graft

16:10 - 16:20M. Trbušić, V. Degoricija, K. Štambuk, J. Dumančić, I. D. Gabrić, D.Planinc

ZagrebMultiple paradoxical embolisms in patient with patent foramen ovale

16:20 - 16:30Z. Miovski, K. Marić Bešić, M. Strozzi, J. Bulum

ZagrebTotal coronary revascularization in young patient with acute coronary syndrome and multivessel disease


16:30 - 16:40 J. Patrk ZadarRadial atery pseudoaneurysm - unexpected com-plication of an unsuccessful intervention

16:40 - 16:50F. Runjić, L.Giunio, I. Vuković, D. Duplančić, A. Jukić, I. Kristić

Split Aortic dissection or coronary artery perforation

16:50 - 17:00J.Šikić, D.Gulin, E.Galić, J.Čerkez Habek

ZagrebPercutaneous Coronary Interventions in Cardiac Allograft Vasculopathy - a case report and review of the literature

17:00 - 17:10 L. Bastiančić, G.Bačić, T. Jakljević Rijeka Mechanical Thrombectomy in STEMI

17:10 - 17:20 M. Pavlov ZagrebInterventional treatment options for simultaneous stroke and myocardial infarction

17:20 - 17:30I.D. Gabrić, T. Krčmar, M. Trbušić, Z. Babić, O. Vinter, H. Pintarić, D. Planinc

ZagrebSuccessful treatment of coronary artery perfora-tion using fat tissue embolization

17:30 - 17:40K. Marić Bešić, Ž. Baričević, M. Strozzi

ZagrebIntracoronary thrombus formation on a guide wire- who is to blame?

17:40 - 17:50M. Trbušić, Z. Babić, M. Pavlov, K. Kordić

ZagrebSpontaneous pneuomopericardium an unusual complication of abdominal carcinoma

17:50 - 18:00 Z. Miovski, J. Bulum, H. Jurin Zagreb STEMI with cardiogenic shock – from bad to worse

18:00 - 18:30 Closing ceremony

20:00 - 23:00 Farewell reception


POSTERS

T. Letilović, D. Kozmar, S. Kranjčević, D. Počanić, H. Jerkić, M. Dragičević, M. Stipinović, E.Kurtić

ZagrebComparison of demographic and procedural characteristitics of ISR vs non-ISR PCI biannual resultsfrom CH Merkur

Z. Miovski, M. Krpan, B. Biočina, J. Bulum ZagrebA saphenous vein graft aneurysm nineteen years after aortocoronary bypass surgery -from diagno-sis until reoperation

M. Sičaja, M.N. Sičaja, B. Starčević ZagrebThe need for standarized premedication protocol for fractional flow reserve (FFR) andinstant wave-free ratio (iFR)- a case report

B. Gardijan, M. Marković, D. Počanić, T. Letilović ZagrebA case of STEMI due to intra-articular lidocaine instillation

B. Starčević, A. Lisičić ZagrebIntravascular ultrasound imaging of recanalized spontaneous coronary artery dissection managed with percutaneous coronary intervention

I. Hadžibegović, B.Vujeva, K. Gabaldo, O. Čančarević, Đ. Prvulović

S. BrodDevelopment of radial access for primary PCI in STEMI in Slavonski Brod: long road to success

L. Giunio, J. Zanchi, A. Bradarić, M .Lozo Split

Radial approach to high risk pulmonary embolism- transcubital catheter directed intervention as a first line therapy in patients with clinically massive and submassive pulmonaly embolism


ZNANSTVENI PROGRAM / SCIENTIFIC PROGRAMME

VI. sastanak intervencijskih kardioloških medicinskih sestara i tehničara

Meeting of Interventional Cardiology Nurses and Technicians

Saturday 12.3.2016.

Chairman: M. Matoš, B. Šego, I. Ferjančić, I. Benko

09:30 - 09:45 I. Benko, A. Ljubas Zagreb Opening

09:45 - 10:00 M. Strozzi ZagrebRight catheterization, rise of forgotten procedure and interventional procedures in congenital heart disease

10:00 - 10:15 T. Krčmar, I. Benko, J. Daskijević ZagrebThe role of the transradial approach in invasive diagnostics and treatment of the periphery arterial disease

10:15 - 10:30 N. Pavlović ZagrebRadiation exposure to medical staff in interventional cardiology: how it could be reduced

10:30 - 10:45 M. Pavletić, V. Puklin ZagrebOptical coherence tomography (OCT) – a new diagnostic techniques in interventional cardiology

10:45 - 11:00 A. Bognar, I. Raić ZagrebEVAR - a method of treatment of abdominal aortic aneurysm stent implantation


Chairman: B. Šego, J. Daskijević, M. Klasan

11:25 - 11:40 M. Kvaternik, P. Stanišić, M. Krpan ZagrebTranscatheter aortic valve implantation – roleof scrub nurse and radiology technician

11:40 - 11:55 B. Šego, K. Radić, M. Slanc ZagrebNursing Responsibilities and Care of the Cardiac Patient Requiring ECMO in Interventional Cardiology


11:55 - 12:05B. Šego, Z. Marić, M. Vrbanić, M. Adamović

Zagreb Successful PCI with ECMO support – Case report

12:05 - 12:15 I. Ferjančić ZagrebPCI Center Without Cardiac Surgery- What to do when a patient with severe coronary disease refuses cardiosurgical treatment - Case report

12:15 - 12:25 R. Palić, D. Šmalcelj, I. Ošlaj Zagreb

Perivcardial tamponade as a fatal complication during atrial septostomy in the critically ill neonate with hypoplastic left heart syndrome and intact atrial septum: A case report as a viewpoint of cardiac catheterization laboratory nurse

12:25 - 12:35I. Benko, Š. Manola, T. Krčmar, N. Pavlović, I. Zeljković, G. Hursa, S. Keleković

Zagreb RF Ablation to ST elevation – Case Report

12:35 - 12:45 S. Blažon ZagrebUrgent sternotomy challenges in Clinical practice of interventional cardiology – Case report

12:45 - 12:55 Discussion



Mjesto i vrijeme održavanja kongresa / Congress venue and date

10.-12. ožujka 2016. / 10. – 12.03.2016.

Hotel The Westin

Izidora Kršnjavoga 1, 10000 Zagreb

Tehnički organizator / PCO professional congress organizer

SPEKTAR PUTOVANJA d.o.o.

A: Tkalčićeva 15, Zagreb, Croatia

T: +385 1 4862 600

F: +385 1 4862 622

E: [email protected]

OPĆE INFORMACIJE / GENERAL INFORMATION


Izložba / Exhibition

▪ Za cijelo vrijeme trajanja planirana je izložba medicinske opreme, lijekova i programa.

Moguće su i sponzorske prezentacije.

▪ During the Congress, there will be an exhibition of medical equipment, pharmaceutical

products and programs.

Potvrda o sudjelovanju / Certificate of Attendance

▪ Svi sudionici s plaćenom kotizacijom dobiti će verificiranu potvrdu o sudjelovanju.

Sudjelovanje liječnika vrednovati će se temeljem Pravilnika o trajnom usavršavanju HLK.

▪ Certificate of Attendance will be issued to all registered participants. Participants of the

congress will be rated according to the Croatian Medical Chamber regulations.

Predavači / Speakers: 16 bodova / points

Slušači / Delegates: 11 bodova / points

Službeni jezik / Official language

▪ Službeni jezici kongresa su hrvatski i engleski. Simultanog prevođenja neće biti

▪ The official languages of the Congress are Croatian and English. No simultaneous

translation will be provided.

Kotizacija / Registration fee

Kategorija / Category

▪ Specijalisti ▪ Specialists 3000,00 Kn / 400 EUR

▪ Med. sestre ▪ Nurses 750,00 Kn / 100 EUR

▪ Osobe u pratnji ▪ Accompanying persons 750,00 Kn / 100 EUR


Vrijeme registracije / Registration and info desk

Četvrtak / Thursday, 10.03.2016.: 15.00 – 19.00

Petak / Friday, 11.03.2016.: 07.15 – 20.00

Subota/ Saturday, 12.03.2016.: 07.15 – 18.30

Vrijeme postavljanja izložbe / Set up time

Četvrtak / Thursday, 10.03.2016. 08.00 – 14.00

Vrijeme raspremanja izložbe / Dismantling time

Subota / Saturday, 12.03.2016. od / from 18.00

Vrijeme izložbe / Exhibition opening hours

Četvrtak / Thursday, 10.03.2016.: 15.00 – 19.00

Petak / Friday, 11.03.2016.: 08.00 – 20.00

Subota / Saturday, 12.03.2016.: 08.00 – 18.00


Dobro došli u Zagreb, glavni grad Republike Hrvatske!

Zagreb je stari srednjoeuropski grad. Stoljećima se razvijao kao bogato kulturno i znanstveno

te snažno trgovačko i gospodarsko središte. Nalazi se na sjecištu važnih prometnica između

jadranske obale i srednje Europe. Zagreb je i poslovno središte, sveučilišni centar, grad kul-

ture, umjetnosti i zabave. Iz Zagreba potječu i u njemu djeluju mnogi glasoviti znanstvenici,

umjetnici i sportaši. Svojim gostima Zagreb nudi barokni ugođaj Gornjega grada, slikovite

tržnice na otvorenom, raznovrsne trgovine i bogat izbor obrtničkih proizvoda, ukusnu do-

maću kuhinju. Zagreb je grad zelenih parkova i šetališta, s brojnim izletištima u prekrasnoj

okolici. U treće tisućljeće ušao je kao milijunski grad. Unatoč brzom razvoju gospodarstva i

prometa, sačuvao je osebujnu ljepotu i ugođaj opuštenosti, što ga čini pravim gradom po

mjeri čovjeka.

ZAGREB / ZAGREB


Welcome to Zagreb, the capital city of the Republic of Croatia!

Zagreb is an old Central European city. For centuries it has been a focal point of culture and

science, and now of commerce and industry as well. It lies on the intersection of important

routes between the Adriatic coast, Central and East Europe. Zagreb is also the hub of the

business, academic, cultural, artistic and sporting worlds in Croatia. Many famed scientists,

artists and athletes come from the city, or work in it. Zagreb can offer its visitors the Baroque

atmosphere of the Upper Town, picturesque open-air markets, diverse shopping facilities, an

abundant selection of crafts and a choice vernacular cuisine. Zagreb is a city of green parks

and walks, with many places to visit in the beautiful surroundings. The city has entered into

the third millennium with a population of one million. In spite of the rapid development of

the economy and transportation, it has retained its charm, and a relaxed feeling that makes

it a genuinely human city.

There’s a whole world of evidence in support of XIENCE.

REAL PROOF FOR THE REAL WORLD

*8,000,000 implants number is based on data of DES implants through Q2 2015. On file at Abbott Vascular. 100,000 patients and 100+ clinical trials numbers are based on trials registered on www.clinicaltrials.gov and www.cvpipeline.com as of July 2015. 10 years is based on first clinical trial studying XIENCE, SPIRIT FIRST, conducted in 2005.

Abbott Vascular International BVBAPark Lane, Culliganlaan 2B, 1831 Diegem, Belgium, Tel: 32.2.714.14.11

Caution: This product is intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use provided inside the product carton (when available) or at eifu.abbottvascular.com for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events. Information contained herein for distribution outside the U.S. only. Check the regulatory status of the device before distribution in areas where CE marking is not the regulation in force.

Tests performed by and data on file at Abbott Vascular. Illustrations are artist’s representations only and should not be considered as engineering drawings or photographs. Photos taken by and on file at Abbott Vascular.

www.AbbottVascular.com ©2015 Abbott. All rights reserved. AP2941919-OUS Rev. A

IMPLANTS*

100,000 PATIENTS STUDIED 100 CLINICAL TRIALS 10 YEARS OF DATA

... AND COUNTING

AV1307-223 NewXience15 1PgAdOUS_M3b.indd 1 12/16/15 3:07 PM


BILJEŠKE / NOTES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Most deliverable DES ,featuring Core Wire Technology

Broadest size matrix to optimise treatment of complex clinical scenarios

Proven long-term safety shown in the

Global RESOLUTE Program2

Resolute Onyx™

ZOTAROLIMUS-ELUTING CORONARY STENT SYSTEM

With

4.5- and 5.0-mm SizesCOMPLEXLV

1 Based on bench test data vs. Promus Premier™* DES, Synergy™* II DES, Xience Xpedition™* DES, Xience Alpine™* DES, BioMatrix NeoFlex™* DES, Orsiro™* DES Ultimaster™* DES and Resolute Integrity™ DES.2 RESOLUTE FIM, RESOLUTE All Comers, RESOLUTE International, RESOLUTE US, RESOLUTE US 38 mm, RESOLUTE Japan, RESOLUTE China RCT, RESOLUTE China Registry, RESOLUTE Asia, RESOLUTE Japan SVS.© 2015 Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. ™* Third-party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company. For distribution only in markets where the Resolute Onyx™ coronary stent has been approved. Not for distribution in the USA, Japan or France. UC201602772ML-02 11/15

BASELINE YEAR 2 YEAR 5

LEARN ABOUT THE FUTURE OF PCI. CALL YOUR ABBOTT VASCULAR SALES REPRESENTATIVE.

OCT images courtesy of RJ van Geuns, Erasmus Medical Center, The Netherlands; De Bruyne B. ABSORB Cohort B 5-year, TCT 2014.

* Small platinum markers at scaffold edges remain.

References: 1. Surreys PW, et al. Lancet 2015; 385(9962): 43-54. 2. Surreys PW, et al. Five-year follow-up of the first-in-man use of a polylactide bioresorbable scaffold eluting everolimus for treatment of coronary stenosis. Presented at TCT 2015, 11-15 October 2015, San Francisco, CA, USA.

Abbott Vascular International BVBA Park Lane, Culliganlaan 2B, 1831 Diegem, Belgium, Tel: 32.2.714.14.11

Caution: This product is intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use provided inside the product carton (when available) or at eifu.abbottvascular.com for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events. Information contained herein for distribution outside the U.S. only. Check the regulatory status of the device before distribution in areas where CE marking is not the regulation in force. Illustrations are artist renditions and not drawn to scale.

Absorb is a trademark of the Abbott Group of Companies.

www.AbbottVascular.com

©2015 Abbott. All rights reserved. 1-EH-2-5593-01 12-2015.

REPAIRS like a best-in-class DES1

RESTORES vessel function2

RENEWS vessel wall structure2

Absorb is a bioresorbable vascular scaffold that dissolves between 2 and 3 years, leaving behind nothing* but a restored vessel—resulting in renewed possibilities for the patient

HAVING NOTHINGCAN MEANEVERYTHING

BIORESORBABLE VASCULAR SCAFFOLD SYSTEM

Absorb

7th national meeting on interventional...

Documents